Zoological institution participation in a West Nile Virus surveillance system: implications for public health.

OBJECTIVE: To identify attributes of zoological institutions and surveillance system factors that were associated with participation in the West Nile Virus Surveillance System for Zoological Institutions in the USA, and to assess the potential effectiveness of zoos as a novel data source for surveillance of emerging infectious zoonoses. STUDY DESIGN: Retrospective. METHODS: The number of specimens submitted between August 2001 and December 2006 for West Nile virus testing was determined for each institution. Descriptive statistics were used to summarize the distribution of number of specimens submitted and features of the institutions. Student's t-test was used to assess potential associations between institutional and animal collection characteristics and the total number of specimens submitted by each institution. RESULTS: Factors associated with institutional participation include: submitting specimens for specific purposes of serosurvey testing, sentinel surveillance, vaccine titre checks, vaccine effectiveness, submitting specimens for multiple reasons, and communication with public health. CONCLUSION: Understanding how zoo and surveillance system characteristics are associated with participation in this surveillance effort may enhance public health efforts and the design of future zoological surveillance efforts.

Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.

BACKGROUND: Growth factor receptor-bound protein-7 (Grb7) is an adapter-type signaling protein recruited to various tyrosine kinases, including HER2/neu. Grb7-specific inhibitors are in early development. As with other targeted therapies, response to therapy might be associated with target expression. MATERIALS AND METHODS: Tissue microarrays containing 638 primary breast cancer specimens with 15-year patient follow-up were employed to assess Grb7 expression using our Automated QUantitative Analysis method; cytokeratin defines pixels as breast cancer (tumor mask) within the histospot, and Grb7 expression within the mask is measured with Cy5-conjugated antibodies. RESULTS: High Grb7 expression was strongly associated with decreased survival in the entire cohort and in the node-positive subset (P = 0.0034 and P = 0.0019, respectively). On multivariable analysis, it remained an independent prognostic marker (P = 0.01). High Grb7 was strongly associated with high HER2/neu, and coexpression of these molecules was associated with worse prognosis than HER2/neu overexpression alone. CONCLUSIONS: High Grb7 defines a subset of breast cancer patients with decreased survival, indicating that Grb7 might be a valuable prognostic marker and drug target. Coexpression with HER2/neu indicates that cotargeting these molecules might be an effective approach for treating HER2/neu-positive breast cancers. Future studies using Grb7-targeting agents should include assessment of Grb7 levels.